Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Todd N who wrote (1752)	4/28/1998 10:21:00 PM
From: B.REVERE	Respond to of 9523

Todd, that was 15 pills average per script. or about $105.00 ($7.00 * 15) to pfe sales' bottom line. Addition to net income would be 105.00 less the expense to produce and market the drug, I believe someone mentioned around $3.48 but that hasn't been verified. Needless to say, if CNBC'S figures are accurate about last week's script rate, then it remains to be seen where the weekly total will level off for the U.S. Once Europe approves in the fall, the total will probably reach into the millions per week.Assuming a profit of $3.50 per pill, pfe will receive about $52.50 ($105.00 * 50% est.expense),multiply that by 1,000,000 per week and pretty soon you have 50 million hitting the bottom line each week. It's hard right now to extrapolate what the bottom line might mean to pfe long term, but any dip will be a buying opportunity for those whose horizons are longer than a couple of weeks. Later,